Literature DB >> 33557078

The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance.

Beata Kowalska-Krochmal1, Ruth Dudek-Wicher1.   

Abstract

Inefficiency of medical therapies used in order to cure patients with bacterial infections requires not only to actively look for new therapeutic strategies but also to carefully select antibiotics based on variety of parameters, including microbiological. Minimal inhibitory concentration (MIC) defines in vitro levels of susceptibility or resistance of specific bacterial strains to applied antibiotic. Reliable assessment of MIC has a significant impact on the choice of a therapeutic strategy, which affects efficiency of an infection therapy. In order to obtain credible MIC, many elements must be considered, such as proper method choice, adherence to labeling rules, and competent interpretation of the results. In this paper, two methods have been discussed: dilution and gradient used for MIC estimation. Factors which affect MIC results along with the interpretation guidelines have been described. Furthermore, opportunities to utilize MIC in clinical practice, with pharmacokinetic /pharmacodynamic parameters taken into consideration, have been investigated. Due to problems related to PK determination in individual patients, statistical estimation of the possibility of achievement of the PK/PD index, based on the Monte Carlo, was discussed. In order to provide comprehensive insights, the possible limitations of MIC, which scientists are aware of, have been outlined.

Entities:  

Keywords:  antibiotics; dilution and gradient methods, interpretation of results; minimal inhibitory concentration; the importance of MIC value

Year:  2021        PMID: 33557078      PMCID: PMC7913839          DOI: 10.3390/pathogens10020165

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  63 in total

Review 1.  Emergence and spread of antibiotic resistance following exposure to antibiotics.

Authors:  Rafael Cantón; María-Isabel Morosini
Journal:  FEMS Microbiol Rev       Date:  2011-07-29       Impact factor: 16.408

2.  Comparison of direct antimicrobial susceptibility testing methods for rapid analysis of bronchial secretion samples in ventilator-associated pneumonia.

Authors:  Flora Kontopidou; Irene Galani; Theofano Panagea; Anastasia Antoniadou; Maria Souli; Elisabeth Paramythiotou; George Koukos; Irene Karadani; Apostolos Armaganidis; Helen Giamarellou
Journal:  Int J Antimicrob Agents       Date:  2011-06-12       Impact factor: 5.283

Review 3.  Polymyxins: Antibacterial Activity, Susceptibility Testing, and Resistance Mechanisms Encoded by Plasmids or Chromosomes.

Authors:  Laurent Poirel; Aurélie Jayol; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

4.  The Search for a Practical Method for Colistin Susceptibility Testing: Have We Found It by Going Back to the Future?

Authors:  Michael J Satlin
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

Review 5.  Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability.

Authors:  Federico Pea; Pierluigi Viale; Mario Furlanut
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

6.  Case-control study of the relationship between MRSA bacteremia with a vancomycin MIC of 2 microg/mL and risk factors, costs, and outcomes in inpatients undergoing hemodialysis.

Authors:  Darego O Maclayton; Katie J Suda; Krista A Coval; Cynthia B York; Kevin W Garey
Journal:  Clin Ther       Date:  2006-08       Impact factor: 3.393

7.  Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections.

Authors:  Jiao Xie; Jason A Roberts; Abdulaziz S Alobaid; Claire Roger; Yan Wang; Qianting Yang; Jinyao Sun; Haiyan Dong; Xue Wang; Jianfeng Xing; Jeffrey Lipman; Yalin Dong
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 8.  Pharmacokinetic and Pharmacodynamic Principles of Anti-infective Dosing.

Authors:  Nikolas J Onufrak; Alan Forrest; Daniel Gonzalez
Journal:  Clin Ther       Date:  2016-07-20       Impact factor: 3.393

9.  Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy.

Authors:  Pamela A Moise-Broder; George Sakoulas; George M Eliopoulos; Jerome J Schentag; Alan Forrest; Robert C Moellering
Journal:  Clin Infect Dis       Date:  2004-05-21       Impact factor: 9.079

Review 10.  What Are the Current Approaches to Optimising Antimicrobial Dosing in the Intensive Care Unit?

Authors:  Ming G Chai; Menino O Cotta; Mohd H Abdul-Aziz; Jason A Roberts
Journal:  Pharmaceutics       Date:  2020-07-07       Impact factor: 6.321

View more
  19 in total

Review 1.  Re-establishing the utility of tetracycline-class antibiotics for current challenges with antibiotic resistance.

Authors:  Kerry L LaPlante; Abhay Dhand; Kelly Wright; Melanie Lauterio
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 2.  Optimizing Antimicrobial Therapy by Integrating Multi-Omics With Pharmacokinetic/Pharmacodynamic Models and Precision Dosing.

Authors:  Hui-Yin Yow; Kayatri Govindaraju; Audrey Huili Lim; Nusaibah Abdul Rahim
Journal:  Front Pharmacol       Date:  2022-06-23       Impact factor: 5.988

3.  Effect of Ciprofloxacin, Levofloxacin, and Ofloxacin on Pseudomonas aeruginosa: A case control study with time kill curve analysis.

Authors:  Tiar Sondang Uli Sihotang; Agung Dwi Wahyu Widodo; Pepy Dwi Endraswari
Journal:  Ann Med Surg (Lond)       Date:  2022-09-16

4.  Comparative genomics reveals response of Rhodococcus pyridinivorans B403 to phenol after evolution.

Authors:  Fang Peng; Meng Ye; Yanfang Liu; Jiashu Liu; Ying Lan; Aihu Luo; Tianyi Zhang; Zhengbing Jiang; Huiting Song
Journal:  Appl Microbiol Biotechnol       Date:  2022-03-12       Impact factor: 4.813

5.  In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori.

Authors:  Maciej Spiegel; Paweł Krzyżek; Ewa Dworniczek; Ryszard Adamski; Zbigniew Sroka
Journal:  Molecules       Date:  2021-12-21       Impact factor: 4.411

6.  Chronic wound isolates and their minimum inhibitory concentrations against third generation cephalosporins at a tertiary hospital in Uganda.

Authors:  Khalim Wangoye; James Mwesigye; Martin Tungotyo; Silvano Twinomujuni Samba
Journal:  Sci Rep       Date:  2022-01-24       Impact factor: 4.379

Review 7.  Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance.

Authors:  Sahaya Nadar; Tabassum Khan; Simon G Patching; Abdelwahab Omri
Journal:  Microorganisms       Date:  2022-01-27

Review 8.  Antimicrobial Susceptibility Testing: A Comprehensive Review of Currently Used Methods.

Authors:  Ina Gajic; Jovana Kabic; Dusan Kekic; Milos Jovicevic; Marina Milenkovic; Dragana Mitic Culafic; Anika Trudic; Lazar Ranin; Natasa Opavski
Journal:  Antibiotics (Basel)       Date:  2022-03-23

Review 9.  New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives.

Authors:  Marco Terreni; Marina Taccani; Massimo Pregnolato
Journal:  Molecules       Date:  2021-05-02       Impact factor: 4.411

10.  Cefiderocol-Based Combination Therapy for "Difficult-to-Treat" Gram-Negative Severe Infections: Real-Life Case Series and Future Perspectives.

Authors:  Davide Fiore Bavaro; Alessandra Belati; Lucia Diella; Monica Stufano; Federica Romanelli; Luca Scalone; Stefania Stolfa; Luigi Ronga; Leonarda Maurmo; Maria Dell'Aera; Adriana Mosca; Lidia Dalfino; Salvatore Grasso; Annalisa Saracino
Journal:  Antibiotics (Basel)       Date:  2021-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.